Amevive

Active Ingredient(s): Alefacept
FDA Approved: * January 30, 2003
Pharm Company: * BIOGEN
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Amevive Overview

Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and Australia. In 2011, the manufacturers made a decision to cease promotion, manufacturing, distribution and sales of Amevive during a supply disruption. According to Astellas Pharma US, Inc.,[1] the decision to cease Amevive sales was neither the result of any specific safety concern nor the result of any FDA-mandated or vol...

Read more Amevive Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alefacept

Recent Amevive Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alefacept
  • Injection: 15mg, 7.5mg
  • Vial: 15mg/vial, 7.5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Alefacept or a similar ingredient: (1 result)